JP2018118936A5 - - Google Patents

Download PDF

Info

Publication number
JP2018118936A5
JP2018118936A5 JP2017012594A JP2017012594A JP2018118936A5 JP 2018118936 A5 JP2018118936 A5 JP 2018118936A5 JP 2017012594 A JP2017012594 A JP 2017012594A JP 2017012594 A JP2017012594 A JP 2017012594A JP 2018118936 A5 JP2018118936 A5 JP 2018118936A5
Authority
JP
Japan
Prior art keywords
polyethylene glycol
enteric
solid preparation
layer
granule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017012594A
Other languages
English (en)
Japanese (ja)
Other versions
JP7064683B2 (ja
JP2018118936A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2017012594A priority Critical patent/JP7064683B2/ja
Priority claimed from JP2017012594A external-priority patent/JP7064683B2/ja
Publication of JP2018118936A publication Critical patent/JP2018118936A/ja
Publication of JP2018118936A5 publication Critical patent/JP2018118936A5/ja
Application granted granted Critical
Publication of JP7064683B2 publication Critical patent/JP7064683B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017012594A 2017-01-27 2017-01-27 腸溶層破損防止用組成物 Active JP7064683B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017012594A JP7064683B2 (ja) 2017-01-27 2017-01-27 腸溶層破損防止用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017012594A JP7064683B2 (ja) 2017-01-27 2017-01-27 腸溶層破損防止用組成物

Publications (3)

Publication Number Publication Date
JP2018118936A JP2018118936A (ja) 2018-08-02
JP2018118936A5 true JP2018118936A5 (ru) 2020-03-05
JP7064683B2 JP7064683B2 (ja) 2022-05-11

Family

ID=63042993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017012594A Active JP7064683B2 (ja) 2017-01-27 2017-01-27 腸溶層破損防止用組成物

Country Status (1)

Country Link
JP (1) JP7064683B2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020055755A (ja) * 2018-09-28 2020-04-09 日本ケミファ株式会社 腸溶性製剤
WO2020218517A1 (ja) * 2019-04-25 2020-10-29 富士製薬工業株式会社 医薬製剤およびその製造方法
JP2021046372A (ja) * 2019-09-19 2021-03-25 日医工株式会社 エソメプラゾール含有製剤
US20230058473A1 (en) * 2020-01-27 2023-02-23 Towa Pharmaceutical Co., Ltd. Esomeprazole oral preparation and method for producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121103B1 (en) 1998-05-18 2006-12-20 Takeda Pharmaceutical Company Limited Orally disintegrable tablets comprising a benzimidazole
US6749867B2 (en) 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
WO2004071374A2 (en) 2003-02-11 2004-08-26 Torrent Pharmaceuticals Limited Once a day orally administered pharmaceutical compositions
CN1263450C (zh) 2005-01-20 2006-07-12 北京科信必成医药科技发展有限公司 奥美拉唑及其衍生物的口腔崩解片及其制备工艺
CN101646421A (zh) 2007-04-26 2010-02-10 卫材R&D管理有限公司 片剂的制备方法
WO2008140459A1 (en) 2007-05-16 2008-11-20 Fmc Corporation Solid form
EP2044932A1 (en) 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Mechanical protective layer for solid dosage forms

Similar Documents

Publication Publication Date Title
JP2018118936A5 (ru)
JP2017105763A5 (ru)
JP2021509912A5 (ru)
EA201390814A1 (ru) Перорально распадающаяся таблетка
JP2016029697A5 (ru)
CL2013001793A1 (es) Comprimido de desintegracion oral de liberacion controlada que comprende i) granulos que contienen lanzoprazol y una capa de recubrimiento que comprende un copolimero y ii) granulos que comprenden lanzoprazol y una capa de recubrimiento que comprende un copolimero y un polimero, con granulos de tamaño medio de no mas de 500 µm.
CL2007001992A1 (es) Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege
JP2015005731A5 (ja) 酸化物半導体膜
CR20160192A (es) Formulación de farmaco de liberación retardada
JP2018003122A5 (ru)
EA201800232A1 (ru) Двухосноориентированные пленки, изготовленные из композиций пропиленового полимера
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
DK3793534T3 (da) Oral tablet til levering af aktive ingredienser til mavetarmkanalen
JP2013231052A5 (ru)
JP2016540026A5 (ru)
ES2623281T3 (es) Composiciones farmacéuticas sólidas con recubrimiento entérico para inhibidores de la bomba de protones.
JP2018041788A5 (ru)
CL2018000246A1 (es) Tableta
RU2015140119A (ru) Таблетка, покрытая кишечнорастворимым покрытием
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
JP2015129175A5 (ru)
JP2019513026A5 (ru)
Utkewicz et al. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid
JP2016013980A5 (ru)
JP2019518052A5 (ru)